We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.
Northern Irish Packaging specialist Sepha says increasing pressure to reduce waste is driving drug industry demand for its range of Press-Out deblistering technologies.
Freeman Technologies, which showcased its FT4 Rheometer at Achema in Frankfurt, Germany, last week, says pharmaceutical powders are complex systems that require analysis of multiple parameters.
ESS Technologies’ says its unique robotic loading system improves the speed, efficiency and accuracy of pharmaceutical manufacturers’ tube filling and closing operations.
St Patrick’s Day celebrations weren’t the only thing bringing people together in New York last week as the pharmaceutical manufacturing and outsourcing industries gathered at the Jacob K Javits convention centre for Interphex 2009.
German coating technology specialist Driam hopes its new Driaconti-T continuous tablet coating platform will win over manufacturers wishing to improve process efficiency in times of economic gloom.
Macao Health Bureau director Lam Ping-yan says tabletting delays at Euopharm Laboratories' plant in Hong Kong, China may have led to contamination of the hyperuricemia drug Purinol (allopurinol) linked to several deaths.
Symetix has launched a compact high-volume optical inspection system that is capable of verifying the colour, size and shape of capsules and tablets and removing defective products.
Indian process technology firm ACE Technologies has won the contract to sell and service GEA Pharma Systems’ range of Courtoy tablet presses to local drug manufacturers as part of the latter company’s Asian expansion plan.
Seidenader Vision is gearing up to launch a modular track and trace (T&T) solution which, it says, will give drug manufacturers the flexibility to adapt to the changing legislative landscape.
To accompany the map detailing job losses, which can be viewed here, we have picked out the details and trends from the data, uncovering the state of US pharmaceutical employment in 2008.
Demand for pharmaceutical manufacturing grade water in Europe shows no sign of drying up, according to a new study by industry analysts Frost & Sullivan.
News that US drugmaker Bristol-Myers Squibb (B-MS) is using its Foam Granulation Technology (FGT) to develop a second drug has worked formulation specialist Dow Wolff Cellulosics (DWC) into quite a lather.
Domino Printing Sciences chose this year’s Emballage world packaging exhibition in Paris, France to showcase the new 5” printhead it has developed for its V300+ thermal transfer printer.
Ethex has withdrawn three lots of its generic drug dextroamphetamine sulphate, which is used to treat ADHD and narcolepsy, after analysis revealed that some oversized tablets had been produced.
Ahead of the “open house” at its facility in Monteriggioni, Siena, Italian machining specialist Marchesini spoke with in-PharmaTechnologist.com about the new plant and its role in the firm's offering to the drug industry.
Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits, while dropping eight disease areas including cholesterol.
Oral dose filling specialist Capsugel hopes that its new Xcelohood containment system will improve industrial weighing operations during the preparation of high-potency drugs.
Drug delivery specialist BioAlliance Pharma says that its decision to focus on the oncology and infectious disease markets helped it reduce its half-year 2008 losses.
Eli Lilly plans to cut 500 jobs, mainly in manufacturing, as it
attempts to restructure its operations to mitigate against the
losses from inhaled insulin.
Stiefel Laboratories, Biopharm Services, Multisorb Technologies,
the Pharmaceutical Research and Manufacturers of America, Catalent
Pharma Solutions and Chromatide have all had people on the
move in the world of pharmaceutical manufacturing.
The use of disposable manufacturing equipment in pharmaceutical
production and greater need for containment equipment were
recurring themes at the Interphex show in Philadelphia last week,
and both were addressed by new equipment...
IntelliPharmaCeutics is ready to move into full-scale clinical
trials with a once-daily oral formulation of oxycodone based on the
company's ReXista abuse- and alcohol-resistant technology.
New research has shown that the FDA's strict 10-month deadline for
a drug's approval following submission may compromise drug safety
and lead to insufficient data for precise drug administration.
The pharmaceutical industry has lost confidence in the UK as a
place to do business to an "alarming degree" and the
situation is only set to deteriorate, reveals new research.
The generic pharmaceutical industry has given short shrift to the
latest congressional attempt to construct a viable approval pathway
for biosimilars in the US.
Redpoint Bio has been issued with a patent for an assay technology
which tests whether a compound enhances or inhibits the bitter or
sweet taste of different ingredients, allowing the company to
screen for flavour enchancing compounds.
The costs of introducing any formal good manufacturing practice
(GMP) requirements for potentially high-risk pharmaceutical
excipients in the European Union would far exceed the likely
benefits, concludes an impact assessment for...
Drug delivery specialist Eurand could see a marked increase in
revenue flow this year, both from co-development products
incorporating the company's formulation technologies and a
proprietary treatment addressing the estimated...
Germany's rap.ID Particle Systems has launched a new lab-ready
particle identification device capable of identifying around 400
particles an hour from 5µm and up. The company says the device is
suited for development and quality...
Germany put in a strong showing as category winners were announced
for the fourth annual Facility of the Year Awards (FOYA)
recognising innovation in pharmaceutical manufacturing projects.
Novartis has announced the US approval of its first-in-class blood
pressure med Tekturna (aliskiren) combined with a diuretic in a
single-tablet formulation.
A starch-based film coating for nutraceuticals which can be
tailored to manufacturer's needs is being developed through a
strategic partnership by Roquette and Biogrund.
Patheon has finally revealed its plans to tackle the ongoing
problems it has been facing with its Puerto Rican operations, which
are draining the firm of profitability.
Swiss pharma Novartis today announced the largest manufacturing investment in its history, revealing plans for a $700m (€486.5m) biotech facility to be built alongside its new solid dose plant in the low cost, high quality biopharma hub of Singapore.
International Journal of Pharmceutics: In Vitro: The dissolution characteristics of five capsules (Next Generation Enteric [NGE], Vcaps® Enteric [VCE],...
